CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 246 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $338,083 | -30.7% | 12,409 | -55.8% | 0.04% | -67.2% |
Q3 2020 | $488,000 | +111.3% | 28,057 | +44.6% | 0.12% | +138.0% |
Q1 2020 | $231,000 | +50.0% | 19,400 | +52.8% | 0.05% | +92.3% |
Q4 2019 | $154,000 | -45.8% | 12,699 | -13.6% | 0.03% | -61.8% |
Q3 2017 | $284,000 | – | 14,700 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INGALLS & SNYDER LLC | 8,609,429 | $55,961,000 | 3.12% |
INVESTOR AB | 1,835,974 | $11,934,000 | 0.86% |
GLOBEFLEX CAPITAL L P | 244,183 | $1,587,000 | 0.40% |
Campbell & CO Investment Adviser LLC | 21,446 | $139,000 | 0.37% |
Birchview Capital, LP | 80,000 | $520,000 | 0.30% |
FEDERATED HERMES, INC. | 13,879,968 | $90,220,000 | 0.26% |
MENTA CAPITAL LLC | 388,582 | $2,526,000 | 0.24% |
Sitrin Capital Management LLC | 40,000 | $260,000 | 0.20% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 172,389 | $1,121,000 | 0.18% |
GSA CAPITAL PARTNERS LLP | 384,976 | $2,502,000 | 0.13% |